Talaris Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Talaris Therapeutics, Inc. (TALS), a late-clinical stage cell therapy company, will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 2:15 PM ET. CEO Scott Requadt will lead this presentation, which aims to highlight Talaris's innovative therapies for solid organ transplantation and severe immune and blood disorders. A live webcast of the event will be available on Talaris's investor webpage, remaining accessible for 30 days post-event.

BOSTON and LOUISVILLE, Ky., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that Scott Requadt, Chief Executive Officer of Talaris, will present at the virtual 40^th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 2:15 PM ET.

A live webcast of the presentation will be available on the investors section of the Talaris website at www.talaristx.com. After the live webcast, the event will remain archived on the Talaris website for 30 days.

About Talaris Therapeutics
Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders. Talaris maintains corporate offices in Boston, MA, its cell processing facility in Louisville, KY, and additional research operations in Houston, TX.

Media Contact
Marin Bergman
Ten Bridge Communications
marin@tenbridgecommunications.com
(818) 516-2746

Investor Contact
Chris Brinzey
ICR Westwicke
chris.brinzey@westwicke.com
(339) 970-2843

FAQ

When will Talaris Therapeutics present at the J.P. Morgan Healthcare Conference?

Talaris Therapeutics will present on January 12, 2022, at 2:15 PM ET.

Who is presenting for Talaris at the healthcare conference?

CEO Scott Requadt will present for Talaris Therapeutics.

Where can I watch the Talaris Therapeutics presentation?

The presentation will be available via live webcast on the Talaris investor website.

How long will the Talaris presentation be available after the event?

The webcast will remain archived on the Talaris website for 30 days.

What is the focus of Talaris Therapeutics?

Talaris focuses on developing therapies for solid organ transplantation and severe immune and blood disorders.